Erythrocin Stearate (PD-Rx Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Erythrocin Stearate drug offered from PD-Rx Pharmaceuticals, Inc.. This Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | PD-Rx Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | ERYTHROMYCIN STEARATE |
SUBSTANCE NAME: | ERYTHROMYCIN STEARATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2011-08-01 |
END MARKETING DATE: | 0000-00-00 |
Erythrocin Stearate HUMAN PRESCRIPTION DRUG Details:
Item Description | Erythrocin Stearate from PD-Rx Pharmaceuticals, Inc. |
LABELER NAME: | PD-Rx Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 250(mg/1) |
START MARKETING DATE: | 2011-08-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 55289-112_5aa99f95-2315-b2cd-e053-2991aa0a5a75 |
PRODUCT NDC: | 55289-112 |
APPLICATION NUMBER: | ANDA060359 |
Other ERYTHROMYCIN STEARATE Pharmaceutical Manufacturers / Labelers: